Fingolimod Capsule
Product Images NDC 68382-912

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 68382-912). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Dccd299a 8330 45b7 A423 5e7695fd8c4c 01)

Chemical structure diagram of Fingolimod, showing its molecular components and arrangement including aromatic ring and functional groups.*

FDA Label Image

Image (Dccd299a 8330 45b7 A423 5e7695fd8c4c 02)

A line graph depicting the percentage of patients with confirmed progression over time (in days) comparing Fingolimod 0.5 mg treatment group and placebo. The y-axis represents percentage, and the x-axis represents treatment duration up to 720 days, showing distinct progression trends for each group.*

FDA Label Image

Image (Dccd299a 8330 45b7 A423 5e7695fd8c4c 03)

Fingolimod Capsules 0.5 mg oral capsules label showing once-daily dosage. The label includes the NDC 68382-912-06, a depiction of a beige capsule marked with '912,' and states the package contains 30 capsules. Manufactured by Cadila Healthcare Ltd and distributed by Zydus Pharmaceuticals USA Inc. Warnings and storage instructions are also present on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.